Ignite Creation Date:
2025-12-24 @ 1:07 PM
Ignite Modification Date:
2026-02-17 @ 7:09 PM
Study NCT ID:
NCT03689361
Status:
COMPLETED
Last Update Posted:
2021-02-03
First Post:
2018-09-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Interest of the T2 * Sequence in MRI for the Diagnosis of Migraine Aura in the Acute Phase.
Sponsor:
University Hospital, Toulouse
Organization:
Study Overview
Official Title:
Interest of the T2 * Sequence in MRI for the Diagnosis of Migraine Aura in the Acute Phase.
Status:
COMPLETED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MARIE
Brief Summary:
investigators hypothesize that T2 \* vein abnormalities are frequent and are specific to the migraine aura.
Detailed Description:
The diagnosis of migraine aura is now based solely on clinical criteria and the assertion of the diagnosis on these clinical criteria alone proves difficult in the acute phase. Added to this difficulty, the symptomatology of a migraine aura can sometimes be similar to that of a stroke, so a diagnosis can be poorly established, resulting in poor patient care. The possibility of making the positive diagnosis of migraine aura on a routine MRI sequence, T2 \*, would be an important advance for the management of these patients
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 2017-004091-60 | EUDRACT_NUMBER | None | View |